Questionnaire

1. Compared with the general population, cardiovascular events and complications in patients with an ARD:

2. PAH is a common cardiovascular complication in patients with:

3. A cardiovascular complication that commonly occurs in patients with RA, SLE and PsO/PsA is:

4. In addition to traditional cardiovascular risk factors and the risks associated with inflammation and atherothrombosis, ARD-associated cardiovascular risk factors include:

5. The impairment in psychological quality of life of patients with PsO exceeds that of patients with other chronic conditions such as malignancy and HF.

6. A PsO variant with life-threatening manifestations is:

7. A PsO variant that occurs more commonly in children is:

8. Patients with mild or severe PsO are at increased risk for:

9. Increasing severity of PsO has been associated with increasing incidence of T2DM and obesity, but not hypertension.

10. Compared with a control population, a South African study on the prevalence of cardiometabolic diseases in a cohort of patients with PsO demonstrated:

11. In patients with PsO and T2DM, a hypoglycaemic agent that has demonstrated effective improvement of PsO skin lesions is:

12. Echocardiography is the first-line imaging technique for the detection of cardiovascular involvement and for monitoring the effects of treatment in ARDs.

13. Echocardiographic features of valvular heart disease associated with ARDs include:

14. CMR findings in patients with TA commonly include:

15. Compared with baseline values, CMR monitoring following anti-TNFα therapy in patients with RA, axSpA or PsA has demonstrated no improvement in: